CARPRIEVE 50 MG TABLETS FOR DOGS

Valsts: Austrālija

Valoda: angļu

Klimata pārmaiņas: APVMA (Australian Pesticides and Veterinary Medicines Authority)

Aktīvā sastāvdaļa:

CARPROFEN

Pieejams no:

NORBROOK LABORATORIES AUSTRALIA PTY LIMITED

SNN (starptautisko nepatentēto nosaukumu):

carprofen(50mg/Tb)

Zāļu forma:

ORAL TABLET

Kompozīcija:

CARPROFEN ANTI-INFLAMMATORY-NONSTEROIDAL Active 50.0 mg/Tb

Vienības iepakojumā:

100 bl.pk; 100 Tablet; 250 bl.pk; 250 Tablet; 50 bl.pk; 500 bl.pk; 500 Tablet

Klase:

VM - Veterinary Medicine

Ārstniecības grupa:

DOG | BITCH | CASTRATE | PUPPY

Ārstniecības joma:

MUSCULOSKELETAL SYSTEM

Ārstēšanas norādes:

ANALGESIC | ANTI-INFLAMMATORY AGENT | INFLAMMATORY JOINT DISEASE | ANTIPYRETIC | BONE SORENESS | BRUISING | BURSITIS | COLIC | INFLAMMATORY RHEUMATIC ARTHRIT | JOINT DISEASE | LIGAMENT SPRAINS | MUSCLE RELAXANT | MUSCLE SORENESS | NON-INFECTIOUS JOINT DISEASE | OSTEOARTHRITIS | PLATELET ACTIVITY | RHEUMATISM | SEDATIVE | SPASMOLYTIC | SPRAINS | STRAINS | TENDON SPRAINS | TRAUMATIC SWELLING

Produktu pārskats:

Poison schedule: 4; Withholding period: whp: n/a; Host/pest details: DOG: [ANALGESIC, ANTI-INFLAMMATORY AGENT, INFLAMMATORY JOINT DISEASE]; Poison schedule: 4; Withholding period: ; Host/pest details: DOG: [ANALGESIC, ANTI-INFLAMMATORY AGENT, INFLAMMATORY JOINT DISEASE]; A non-steroidal anti-inflammatory drug for the relief of pain and inflammation in dogs.DO NOT use in cats - see Contraindications/Precautions on label.

Autorizācija statuss:

Registered

Autorizācija datums:

2023-07-01

Lietošanas instrukcija

Carprieve 50mg
50 x Blister Carton
Label
file
name: 54884_
44396_50B_primary
_M
PL_
V1.pdf
100% Actual 1
:1
Size=
55 x 22.5 x 130mm
(100%
when
printed
on
A4
paper)
16/6/08
'~."
APPROVED
LABEL
Info
PEST


Verified
Carprieve
50mg
100 x Blister Carton
Label
file
name: 54884_44396_100B_primary_MPL_V1.pdf
100% Actual 1
:1
Size
=
55 x 40 x
130mm
l:J
o
JJ
•
..•
I
~
•Jtlllt
••
!
2.!1
~
Norbrooll
~
(66%
when
printed
on
A4
and
100%
when
printed
on
A3
paper)
12/6/08
·~~!Ia
.
'
~
''
'
' '
'
ilii
""li
'
-
'
.:n
· · ·
c£
·
..
·
'
"'If·
. ,
.:r
'
i1.:::l.:
j
t:-~
m:
:u
=-···
:]{o]l
r.;m
r;~;
l~'"'
••luf'
<•l,'J
liii7T1J
cr.r.r!l.P
·r:Iil
ll!Hil
APPROVED
LABEL
Carprieve 50mg
100 Tablet Label
Label file name: 54884_
44396_1
OOT
_immediate_MPL_
V1.pdf
100%
Actual1:1
Size=
33 x
89mm
(100%
when
printed
on
A4
paper)
16/6/08
APPROVED
LABEL
1
·
:"t
I
,'L;J:t
,(IJ.-":1
'ill
, , ·
•1r~
, ,
"'!I
Ll]
•·
cUI·•lll•
.r;r,;l
,,
U
:J
··
•
.r;r,,
';J1
T·TI
~·~''
~'
"''
·'""'
~
~.~
''
..
:lllJ.i'j
:1'
' '
'
or.
'
'
.,
...
,
Norbrooll
~
Carprieve 50mg
250 x Blister Carton
Label
file
name: 54884_44396_250B_primary_MPL_V1.pdf
100% Actual1:1
Size=
120 x 58 x 133mm
(66%
when
printed on
A4
and
100%
when
printed on A3 paper)
12/6/08
Norbrooll
~
(!)
...........
.
•••••••
Bab:h:
Ellpllr.
APPROVED
LABEL
Carprieve 50mg
250 Tablet Label
Label
file
name: 54884_
44396_250T
_immediate_MPL_V1.pdf
100% Actual1:1
Size=
49 x 131.75mm
(1
00%
when
printed on
A4
paper)
READ
THE
ENCLOSED
LEAFLET
BEFORE
USING
THIS
PRODUCT
DIRECTIONS
FOR
USE
Dosage:
2-4
mg/kg
bodyweight
per
day.
Dose,
frequency
and
duration
of
treatment
will
be
dependent
upon
clinical
response.
See
leaflet
for
full
details.
12/6/08
APPROVED
LABEL
I'
'
'
ill-
..... '
.
[:!'"t'1,
llil'
• ·
•
•
·I
o.l"i[
;1
,
•
!!i
lr.r'·
.
.,
:i.
'
"
' . '
m i
TO
'ill•
~'
,,,,,..
··u.u.·
'U!l!
TI:
' '
~.3
NORBROOJI
.:S
Carprieve
50mg
500 x Blister Carton
Label
file
name: 54884_
44396_500B_primary
_MPL_
V1.pdf
100% Actual1:1
Size=
205 x 57 x
135mm

Produkta apraksts

PRODUCT NAME: CARPRIEVE TABLETS FOR DOGS
PAGE: 1 OF 4
THIS REVISION ISSUED: JANUARY, 2010
MATERIAL SAFETY DATA SHEET
Issued by: Norbrook Laboratories Australia Pty Ltd
Freecall: 1800 665 866
POISONS INFORMATION CENTRE: 13 1126 FROM ANYWHERE IN AUSTRALIA, (0800
764 766 IN NEW ZEALAND)
SECTION 1 - IDENTIFICATION OF CHEMICAL PRODUCT AND COMPANY
NORBROOK LABORATORIES AUSTRALIA PTY LTD
FREECALL: 1800 665 866
UNIT 7/1 TRADE PARK DRIVE
TULLAMARINE, VIC 3043 AUSTRALIA
SUBSTANCE:
Non-steroidal anti-inflammatory drug in a suitable carrier.
TRADE NAME:
CARPRIEVE TABLETS FOR DOGS
APVMA CODES:
54885 (20mg/tab) & 54884 (50mg/tab) & 63022 (100mg/tab) Three products
with
different levels of active.
PRODUCT USE:
A non-steroidal anti-inflammatory drug for the relief of pain and
inflammation in dogs.
CREATION DATE:
JUNE, 2009
THIS VERSION ISSUED:
JANUARY, 2010
and is valid for 5 years from this date.
SECTION 2 - HAZARDS IDENTIFICATION
STATEMENT OF HAZARDOUS NATURE
This product is classified as:
Not classified as hazardous according to the criteria of ASCC.
Not a Dangerous Good according to the Australian Dangerous Goods (ADG)
Code.
RISK PHRASES:
Not Hazardous - No criteria found.
SAFETY PHRASES:
S22, S25. Do not breathe dust. Avoid contact with eyes.
SUSDP CLASSIFICATION:
S4
ADG CLASSIFICATION:
None allocated. Not a Dangerous Good under the ADG Code.
UN NUMBER:
None allocated
EMERGENCY OVERVIEW
PHYSICAL DESCRIPTION & COLOUR
: A white to off-white circular tablet.
ODOUR:
No data.
MAJOR HEALTH HAZARDS:
no significant risk factors have been found for this product. This is
a physiologically active
product and so contact should be minimised, especially if the user is
taking a form of medication, as interactions can
sometimes give unexpected and undesired results.
POTENTIAL HEALTH EFFECTS
INHALATION:
SHORT TERM EXPOSURE:
Available data indicates that this product is not harmful. In addition
product is unlikely to
cause any discomfort or irritation.
LONG TERM EXPOSURE:
No data for health effects associated with long term inhalation.
SKIN